Retraction: Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2−/− mice and human cholangiocarcinoma tumorigenesis

Le résumé fourni par la source

At the request of Indiana University, the Editors and Publisher retract this original article by Kennedy et al,1 published in the September 2018 issue of Hepatology. A joint research misconduct investigation led by Indiana University determined that falsification occurred during creation of the publication and research misconduct findings were made against one or more co-authors, including the last author of the publication. As a result, the participating institutions request that the article be retracted to correct the scientific record. The authors have been informed of the retraction.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.